Home » Integra Launches Suturable DuraGen Dural Regeneration Matrix
Integra Launches Suturable DuraGen Dural Regeneration Matrix
April 18, 2005
Integra LifeSciences Holdings announced it has received 510(k) clearance from the FDA to market the Suturable DuraGen Dural Regeneration Matrix in the U.S. Suturable DuraGen, the third generation in Integra LifeSciences' line of absorbable onlay collagen matrix grafts for cranial and spinal dural repair, provides the surgeon with the ability to use the graft as either an onlay graft or as a sutured graft.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct